NBCNews.com |
Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade
NBCNews.com Everyone hopes and wishes for that last-minute cancer breakthrough that will save doomed patients. It almost never actually happens. With Gleevec, it did. The once-a-day pill turned chronic myelogenous leukemia, or CML, from a certain death sentence … Imatinib Continues to Impress in Long-Term CML Analysis ‘Imatinib Changed Everything’: The Future Is Now More Hopeful Leukemia drug fends off cancer for a decade, study shows |
View original article
Author:
Powered by WPeMatico